|
CCDC112 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.991500E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.903700E-03 |
| Normal-vs-Stage2 |
1.099640E-01 |
| Normal-vs-Stage3 |
1.596810E-03 |
| Normal-vs-Stage4 |
3.142300E-02 |
| Stage1-vs-Stage2 |
8.255000E-01 |
| Stage1-vs-Stage3 |
3.916000E-02 |
| Stage1-vs-Stage4 |
6.668500E-02 |
| Stage2-vs-Stage3 |
2.560200E-01 |
| Stage2-vs-Stage4 |
2.401600E-01 |
| Stage3-vs-Stage4 |
7.203000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.181900E-03 |
| Normal-vs-AfricanAmerican |
6.724400E-03 |
| Normal-vs-Asian |
3.062800E-03 |
| Caucasian-vs-AfricanAmerican |
7.345000E-01 |
| Caucasian-vs-Asian |
1.307400E-01 |
| AfricanAmerican-vs-Asian |
2.074800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.776040E-02 |
| Normal-vs-Female |
6.04429999999656E-05 |
| Male-vs-Female |
1.539600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.740360E-02 |
| Normal-vs-Extreme_Weight |
4.595800E-02 |
| Normal-vs-Obese |
2.363000E-03 |
| Normal-vs-Extreme_Obese |
5.742000E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.186600E-01 |
| Normal_Weight-vs-Obese |
8.447800E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.305200E-01 |
| Extreme_Weight-vs-Obese |
1.986600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.672000E-01 |
| Obese-vs-Extreme_Obese |
2.117800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.433100E-04 |
| Normal-vs-Age(41-60Yrs) |
3.54620000000416E-05 |
| Normal-vs-Age(61-80Yrs) |
1.268590E-01 |
| Normal-vs-Age(81-100Yrs) |
2.106000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.302300E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.767100E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.823800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.380500E-04 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.885600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.149400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.984400E-03 |
| Normal-VS-Type2 PRCC |
6.366200E-02 |
| Normal-VS-KIRP CIMP |
8.35399999999931E-05 |
| Normal-VS-Unclassified PRCC |
2.938200E-03 |
| Type1 PRCC-VS-Type2 PRCC |
2.922800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.997880E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.888390E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.546100E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
5.582200E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
4.499600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.226400E-01 |
| Normal-vs-N1 |
3.86300000000395E-05 |
| Normal-vs-N2 |
4.861200E-01 |
| N0-vs-N1 |
3.352900E-04 |
| N0-vs-N2 |
9.361000E-01 |
| N1-vs-N2 |
9.984300E-02 |
|
|
